Results 91 to 100 of about 17,702 (177)

Caspofungin in vivo hatékonysága Candida parapsilosis, Candida orthopsilosis és Candida metapsilosis izolátumok ellen neutropéniás egérmodellben

open access: yes, 2012
Az utóbbi években a neutropéniás betegek esetében a Candida albicans mellett, a nem albicans fajok is megjelentek mint a C. parapsilosis, amelyen belül molekuláris biológiai módszerek segítségével másik két fajt: a Candida orthopsilosist és a C ...
Joó, Imre
core  

Sensitivity of the CnaA truncation strains to Caspofungin.

open access: yes, 2013
CnaA truncation expression strains were cultured on GMM agar in the presence of varying concentrations of the cell wall inhibitor caspofungin for 5 days.
Praveen R. Juvvadi (449281)   +10 more
core   +1 more source

Systematic analysis of echinocandin-associated adverse reactions using the FAERS database: identification of unique DRESS and resistance signals

open access: yesFrontiers in Medicine
AimThis pharmacovigilance study analyzed echinocandin-related adverse events (AEs) using the FDA Adverse Event Reporting System (FAERS) database to identify agent-specific safety signals and inform clinical decision-making.MethodsAE reports were ...
Xue Zhang   +5 more
doaj   +1 more source

Application of caspofungin in China compared with amphotericin B and fluconazole

open access: yes, 2014
Chunyu Zhang,1 Jiaoying Cheng,2 Yan Jiang,3 Junyang Liu41Department of Health Reform and Development, China–Japan Friendship Hospital, Beijing, People’s Republic of China; 2Department of Obstetrics and Gynecology, China–Japan Friendship
Jiang Y, Liu JY, Cheng JY, Zhang CY
core  

Development and Quality Control of a Population Pharmacokinetic Model Library for Caspofungin

open access: yesPharmaceutics
Background: Caspofungin is an echinocandin antifungal agent commonly used as the first-line therapy for invasive candidiasis, salvage therapy for invasive aspergillosis, and empirical therapy for presumed fungal infections.
Nuo Xu   +11 more
doaj   +1 more source

Pharmacokinetics of Caspofungin Acetate in Healthy Adult Cats [PDF]

open access: yes, 2018
Background Sino-orbital aspergillosis (SOA) is an invasive fungal infection with high mortality due to difficulty in its treatment. SOA is commonly caused by cryptic species in Aspergillus section Fumigati that are often resistant to antifungal triazoles
Leshinsky, Jana
core  

Caspofungin

open access: yes, 2017
Caspofungin es un antifúngico perteneciente al grupo de las equinocandinas. Ejerce el mecanismo de acción inhibiendo la síntesis de (1,3)-β-D-glucano de la pared celular fúngica.
Hamdan Suleiman, Gamal
core  

Detection of Caspofungin Resistance in Candida spp. by Etest

open access: yes, 2008
International audienceThe caspofungin susceptibilities of 28 Candida sp. clinical isolates, including 8 caspofungin-resistant isolates characterized by mutations in the Fks1 protein, were determined by the Etest in RPMI and AM3 media. Good discrimination
Desnos-Ollivier, Marie   +2 more
core   +1 more source

Population pharmacokinetics of caspofungin in critically ill patients receiving extracorporeal membrane oxygenation—an ASAP ECMO study

open access: yes
This study aimed to describe the population pharmacokinetics of caspofungin in critically ill patients receiving extracorporeal membrane oxygenation (ECMO) and to identify dosing regimens with a high likelihood of achieving effective exposures.
McGuinness, Shay   +14 more
core   +1 more source

Comparison of Vitek 2C antifungal susceptibility testing with broth microdilution testing for Candida species [PDF]

open access: yesMedical Laboratory Journal
Background: The reference method for antifungal susceptibility testing is broth microdilution according to Clinical and Laboratory Standard Institute (CLSI) guidelines.
Sukanya Sudhaharan   +2 more
doaj  

Home - About - Disclaimer - Privacy